ArrayPatch Ltd, a biotechnology firm based in Cork, Ireland, has completed the initial closing of a €3 million seed funding round. The company is focused on advancing ITZ-Dermap™, a microneedle-based therapeutic designed to treat nail fungus.
The funds will support further development and clinical evaluation of ITZ-Dermap™, aiming to provide an innovative alternative to current antifungal treatments.
**Why this matters**
Nail fungus is a common condition that can be difficult to treat effectively with existing therapies. ArrayPatch’s microneedle technology has the potential to improve drug delivery directly to the affected area, potentially increasing treatment efficacy and patient outcomes. This funding milestone marks a significant step toward bringing a new treatment option to market.
Source: NewsData